Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.

Neurodegeneration in Parkinson's, Alzheimer's, and other neurodegenerative diseases seems to be multifactorial, in that a complex set of toxic reactions including inflammation, glutamatergic neurotoxicity, increases in iron and nitric oxide, depletion of endogenous antioxidants, reduced expression of trophic factors, dysfunction of the ubiquitin-proteasome system, and expression of proapoptotic proteins leads to the demise of neurons. Thus, the fundamental objective in neurodegeneration and neuroprotection research is to determine which of these factors constitutes the primary event, the sequence in which these events occur, and whether they act in concurrence in the pathogenic process. This has led to the current notion that drugs directed against a single target will be ineffective and rather a single drug or cocktail of drugs with pluripharmacological properties may be more suitable. Green tea catechin polyphenols, formerly thought to be simple radical scavengers, are now considered to invoke a spectrum of cellular mechanisms of action related to their neuroprotective activity. These include pharmacological activities like iron chelation, scavenging of radicals, activation of survival genes and cell signaling pathways, and regulation of mitochondrial function and possibly of the ubiquitin-proteasome system. As a consequence these compounds are receiving significant attention as therapeutic cytoprotective agents for the treatment of neurodegenerative and other diseases.

[1]  R. Stackman,et al.  Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment , 2003, Experimental Neurology.

[2]  M. Pericak-Vance,et al.  Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.

[3]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[4]  Y. L. Lin,et al.  Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. , 1999, European journal of pharmacology.

[5]  B. Ahlemeyer,et al.  Neuroprotective effects of Ginkgo biloba extract , 2003, Cellular and Molecular Life Sciences CMLS.

[6]  R. Martins,et al.  Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β , 2003, Brain Research Reviews.

[7]  F. V. Defeudis,et al.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.

[8]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[9]  M. Mattson,et al.  Essential role for integrin linked kinase in Akt‐mediated integrin survival signaling in hippocampal neurons , 2003, Journal of neurochemistry.

[10]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[11]  M. Youdim,et al.  Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein* , 2002, The Journal of Biological Chemistry.

[12]  Jen-kun Lin,et al.  Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IκB kinase activity in macrophages , 2000 .

[13]  C. Rice-Evans,et al.  Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[15]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[16]  C. Lavedan The synuclein family. , 1998, Genome research.

[17]  David Blum,et al.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.

[18]  C. Rice-Evans,et al.  Dietary Flavonoids as Potential Neuroprotectants , 2002, Biological chemistry.

[19]  R. Hider,et al.  Metal chelation of polyphenols. , 2001, Methods in enzymology.

[20]  S. Korsmeyer,et al.  Bcl-2 gene family in the nervous system. , 1997, Annual review of neuroscience.

[21]  S. Suh,et al.  The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .

[22]  W. May,et al.  A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis* , 1998, The Journal of Biological Chemistry.

[23]  D. Tagliazucchi,et al.  Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin , 2003, Brain Research Bulletin.

[24]  S. Mandel,et al.  cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  M. Hiramatsu,et al.  The efficacy of an antioxidant cocktail on lipid peroxide level and superoxide dismutase activity in aged rat brain and DNA damage in iron-induced epileptogenic foci. , 2000, Toxicology.

[26]  M. Vila,et al.  α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP , 2000, Journal of neurochemistry.

[27]  C. Hofmann,et al.  Green tea polyphenol epigallocatechin‐3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  George Adelman,et al.  Encyclopedia of neuroscience , 2004 .

[29]  S. Mandel,et al.  cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.

[30]  Z. Szallasi,et al.  Overexpression of Protein Kinase C Isoform but not δ in Human Interleukin-3–Dependent Cells Suppresses Apoptosis and Induces bcl-2 Expression , 1998 .

[31]  M. Ebadi,et al.  Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease , 2001, Neurosignals.

[32]  J. Joseph,et al.  A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.

[33]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[34]  Z. Y. Wang,et al.  Tea and cancer. , 1993, Journal of the National Cancer Institute.

[35]  S. Mandel,et al.  Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.

[36]  M. Folstein,et al.  Nonsteroidal anti-inflammatory drugs in Alzheimer's disease , 1995, Neurology.

[37]  Yona Levites,et al.  Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action* , 2002, The Journal of Biological Chemistry.

[38]  C. Rice-Evans,et al.  Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. , 2001, The Biochemical journal.

[39]  S. Wessler,et al.  A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation* , 2004, Journal of Biological Chemistry.

[40]  Y. Lou,et al.  Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. , 1994, Cancer research.

[41]  M. Tabata,et al.  Effects of pH and Metal Ions on Antioxidative Activities of Catechins , 2001, Bioscience, biotechnology, and biochemistry.

[42]  J. Greenwood,et al.  Letter: Exploration of the common bileduct. , 1974, Lancet.

[43]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[44]  M. Masuda,et al.  Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  S. Mandel,et al.  Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. , 2003, Trends in pharmacological sciences.

[46]  D. Allsop,et al.  alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. , 2001, Free radical biology & medicine.

[47]  S. Suh,et al.  Protective effects of the green tea polyphenol (−)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils , 2000, Neuroscience Letters.

[48]  Xiaofeng Meng,et al.  Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[49]  G. Escames,et al.  Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion , 2003, Neurobiology of Aging.

[50]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[51]  E. Mandelkow,et al.  Proteolysis by presenilins and the renaissance of tau. , 1999, Trends in cell biology.

[52]  D. Small,et al.  A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  H. Mukhtar,et al.  Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells , 2003, Oncogene.

[54]  J. Melki,et al.  Spinal muscular atrophy. , 1997, Current opinion in neurology.

[55]  P. Reiner,et al.  Regulation of Amyloid Precursor Protein Cleavage , 1999, Journal of neurochemistry.

[56]  T. Sunderland,et al.  Physiologic Levels of β‐Amyloid Activate Phosphatidylinositol 3‐Kinase with the Involvement of Tyrosine Phosphorylation , 1996, Journal of neurochemistry.

[57]  R. Yu,et al.  Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death , 2000, Archives of pharmacal research.

[58]  Tianhong Pan,et al.  Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. , 2003, Life sciences.

[59]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[60]  Ji Hyun Han,et al.  Dual mechanisms of green tea extract‐induced cell survival in human epidermal keratinocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  K. Senior Dosing in phase II trial of Alzheimer's vaccine suspended , 2002, Lancet Neurology.

[62]  Y. Kan,et al.  Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. , 1999, Bioscience, biotechnology, and biochemistry.

[63]  M. Diaz-Meco,et al.  Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade , 1997, Molecular and cellular biology.

[64]  C. Olanow,et al.  Iron and neurodegeneration , 1996 .

[65]  B. Frei,et al.  Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.

[66]  A. Kong,et al.  Antioxidants and oxidants regulated signal transduction pathways. , 2002, Biochemical pharmacology.

[67]  R. A. Oliveira,et al.  Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. , 2003, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[68]  J. Ducobu,et al.  OCULAR TOXICITY OF DESFERRIOXAMINE , 1985, The Lancet.

[69]  M. Bähr,et al.  Insulin-Like Growth Factor-I Protects Axotomized Rat Retinal Ganglion Cells from Secondary Death via PI3-K-Dependent Akt Phosphorylation and Inhibition of Caspase-3 In Vivo , 2000, The Journal of Neuroscience.

[70]  Q. Guo,et al.  Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. , 1996, Biochimica et biophysica acta.

[71]  C. Heckman,et al.  The sevenfold way of PKC regulation. , 1998, Cellular signalling.

[72]  B. Shukitt-Hale,et al.  Fruit Polyphenolics and Brain Aging , 2002 .

[73]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[74]  S. Mandel,et al.  Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin , 2003, Annals of the New York Academy of Sciences.

[75]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[76]  A. Takashima,et al.  Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.

[77]  R. Scheller,et al.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane. , 1991, Brain research. Molecular brain research.

[78]  D. Jiang,et al.  Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice , 2005, Journal of Neural Transmission.

[79]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[80]  J. Grotta,et al.  Ethanol Plus Caffeine (Caffeinol) for Treatment of Ischemic Stroke: Preclinical Experience , 2003, Stroke.

[81]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[82]  H. Hasegawa,et al.  Ameliorative effects of tea catechins on active oxygen-related nerve cell injuries. , 1995, The Journal of pharmacology and experimental therapeutics.

[83]  M. Kyriazis,et al.  Neuroprotective, anti-apoptotic effects of apomorphine. , 2003, Journal of anti-aging medicine.

[84]  K. Jellinger,et al.  Neuropathological spectrum of synucleinopathies , 2003, Movement disorders : official journal of the Movement Disorder Society.

[85]  D. Mochly‐Rosen,et al.  Opposing roles of δ and εPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery , 2003 .

[86]  M. Youdim,et al.  The Future of Neuroprotection , 1999, Annals of the New York Academy of Sciences.

[87]  D. Praticò,et al.  Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. , 2000, The American journal of medicine.

[88]  K. Murai,et al.  Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling , 2003, Nature Neuroscience.

[89]  S. Mandel,et al.  Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration , 2001, Journal of neurochemistry.

[90]  M. Hiramatsu,et al.  Effect of “βCATECHIN” on the life span of senescence accelerated mice (SAM‐P8 strain) , 1997 .

[91]  L. Mucke,et al.  Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease , 1997, Brain Research Reviews.

[92]  Barbara Shukitt-Hale,et al.  Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.

[93]  John Hardy,et al.  The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity , 2000, The Journal of Neuroscience.

[94]  M. Beal,et al.  Bioenergetic approaches for neuroprotection in Parkinson's disease , 2003, Annals of neurology.

[95]  J. Lin,et al.  Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. , 1999, Biochemical pharmacology.

[96]  H. Xue,et al.  Naturally occurring 2'-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands. , 2003, Biochemical pharmacology.

[97]  P. Lazarovici,et al.  Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections , 2002, Science.

[98]  M. Youdim,et al.  The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing , 2003, The FASEB Journal.

[99]  C. S. Patil,et al.  Protective Effect of Flavonoids against Aging- and Lipopolysaccharide-Induced Cognitive Impairment in Mice , 2003, Pharmacology.

[100]  D. Ben-shachar,et al.  The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons , 1991, Journal of neurochemistry.

[101]  P. Riederer,et al.  Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.

[102]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[103]  S. Mandel,et al.  Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallate , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  P. Bauer,et al.  Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra , 2003, Neuroscience Letters.

[105]  R. Tyrrell,et al.  Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. , 2001, The Biochemical journal.

[106]  W. Kalt,et al.  Feeding Rats Diets Enriched in Lowbush Blueberries for Six Weeks Decreases Ischemia-induced Brain Damage , 2002, Nutritional neuroscience.

[107]  C. Rice-Evans,et al.  MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide , 2002, Neurobiology of Aging.

[108]  J. Medina,et al.  Overview—Flavonoids: A New Family of Benzodiazepine Receptor Ligands , 1997, Neurochemical Research.

[109]  Y. Suh,et al.  α‐Synuclein regulates neuronal survival via Bcl‐2 family expression and PI3/Akt kinase pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  M. Youdim,et al.  Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28 , 2004, Annals of the New York Academy of Sciences.

[111]  D. Deleu,et al.  Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson’s Disease , 2002, Clinical pharmacokinetics.

[112]  M. Chevion,et al.  Protective effects of tea polyphenols against oxidative damage to red blood cells. , 1997, Biochemical pharmacology.

[113]  C. Rice-Evans,et al.  Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. , 1995, Archives of biochemistry and biophysics.

[114]  E. Masliah,et al.  Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease* , 1999, The Journal of Biological Chemistry.

[115]  M. Vila,et al.  Neurological diseases: Targeting programmed cell death in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.

[116]  D. Selkoe,et al.  Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.

[117]  F. Nanjo,et al.  Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. , 1996, Free radical biology & medicine.

[118]  K. Z. Itil,et al.  A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo biloba Extract EGb 761® in Dementia , 2000, Dementia and Geriatric Cognitive Disorders.

[119]  D. Dorsa,et al.  The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.

[120]  M. Youdim,et al.  Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats , 2004, Neuropharmacology.

[121]  B. Shukitt-Hale,et al.  Blueberry Supplementation Enhances Signaling and Prevents Behavioral Deficits in an Alzheimer Disease Model , 2003, Nutritional neuroscience.

[122]  Harvey Checkoway,et al.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.

[123]  J. Connor,et al.  Redox-active metals in neurological disorders , 2004 .

[124]  C. Rice-Evans,et al.  The relative antioxidant activities of plant-derived polyphenolic flavonoids. , 1995, Free radical research.

[125]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[126]  D. Commenges,et al.  Intake of flavonoids and risk of dementia , 2000, European Journal of Epidemiology.

[127]  L. Mucke,et al.  Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[128]  S. Kohsaka,et al.  Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons , 1998, Journal of neuroscience research.

[129]  Y. Fujimura,et al.  A receptor for green tea polyphenol EGCG , 2004, Nature Structural &Molecular Biology.

[130]  C. Pike,et al.  Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.

[131]  P. Parker,et al.  Loss of protein kinase C function induces an apoptotic response , 1998, Oncogene.

[132]  S. Gupta,et al.  Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[133]  M. Mattson,et al.  Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. , 2003, Trends in molecular medicine.

[134]  P. Maher How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death , 2001, The Journal of Neuroscience.

[135]  G. Linazasoro Neuroprotection in Parkinson’s disease: love story or mission impossible? , 2002, Expert review of neurotherapeutics.

[136]  C. Olanow,et al.  Neurodegeneration and Neuroprotection in Parkinson's Disease , 1996 .